COVID-19 Clinical Trial
Official title:
Effectiveness of Home-based Telehealth Exercise Training Program for Post-COVID Patients: A Randomized Controlled Trial
The aim of our study is to investigate the effectiveness of telehealth exercise training programs in Post-COVID patients.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | October 8, 2024 |
Est. primary completion date | September 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion Criteria: Individuals who had been diagnosed with COVID-19 positive and whose last PCR test or rapid antigen test was negative with the following criteria: - aged between 20 to 80 years old - persistent symptoms at least 4 weeks after recovery from COVID-19 infection, including any of the following symptoms: dyspnea, fatigue, cough, headache, chest tightness, palpitations, loss of smell, anxiety, insomnia, brain fog or joint pain - able to speak and understand Mandarin - no cognitive impairment (Mini-Mental State Examination > 24) - able to walk including those who need the walking aid - had mobile phones and could easily access the Internet Exclusion Criteria: - a history of chronic obstructive pulmonary disease or other respiratory diseases - a history of arrhythmia,cancer, end-stage renal disease with dialysis, being diagnosed with mental illness, recent stroke within 6 months - inability to participate because of comorbid neurological or musculoskeletal conditions that produce moderate to severe physical disability - need all day oxygen support |
Country | Name | City | State |
---|---|---|---|
Taiwan | Tri-service general hospital | Taipei | Neihu |
Lead Sponsor | Collaborator |
---|---|
Tri-Service General Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in exercise capacity: peak oxygen uptake (VO2peak) | The peak oxygen uptake (VO2peak) is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). | 3 months | |
Primary | Change in exercise capacity: workload (Watt) | The workload (Watt) is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). | 3 months | |
Primary | Change in exercise capacity: anaerobic threshold (AT) | The anaerobic threshold (AT) is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). | 3 months | |
Secondary | Change in Physical Activity Amounts: Taiwan version of the International Physical Activity Questionnaire | Taiwan version of the International Physical Activity Questionnaire. The overall physical activity (MET-min/week), vigorous intensity physical activity (MET-min/week), moderate intensity physical activity (MET-min/week), walking (MET-min/week), and sitting behavior (min/week) are measured. | 3 months | |
Secondary | Change in confidence level of exercise: Questionnaire of Self-Efficacy Items | Questionnaire of Self-Efficacy Items. A five-item self-efficacy measure designed to measure confidence in one's ability to persist with exercising in various situations was developed. A five-point scale is used to rate each item : 1 indicates "not at all confident", 2 indicates "little confident" , 3 indicates "confident", 4 indicates "very confident", 5 indicates "strongly confident". | 3 months | |
Secondary | Change in Health-Related Quality of Life: Taiwan version of World Health Organization Quality-of-Life Questionnaire (WHOQOL-BREF) | The WHOQOL-BREF Taiwan version is simplified from the WHOQOL long form for Taiwan. It contains 28 items. ( 26 items organized into 4 domains, and 2 items on overall quality of life and general health) The 4 domains are Physical Health, Psychological, Social Relationships and Environment. Three negatively phrased items are reversed scored. Domain scores are computed by taking the mean of the scores of the items that constitute the domain and multiplied by 4 so that the scores are directly comparable with those derived from WHOQOL-100. | 3 months | |
Secondary | Change in sleep quality: Pittsburgh Sleep Quality Index (PSQI) | Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a l-month time interval. Nineteen individual items generate seven "component" scores and the sum of scores for these seven components yields one global score. (Scores ranged from 0 to 21, with higher scores indicating poor sleep quality.) | 3 months | |
Secondary | Change in lung function: Forced expiratory volume 1 (FEV1) | The amount of air exhaled (mL) during the first second during a forced expiratory volume test will be measured by spirometry. | 3 months | |
Secondary | Change in lung function: Forced Vital Capacity (FVC) | The total amount of air exhaled (mL) during a forced expiratory volume test will be measured by spirometry. | 3 months | |
Secondary | Change in lung function: FEV1/FVC % | The measured FEV1 is divided by the measured FVC. | 3 months | |
Secondary | Change in lung function: Total lung capacity | Total lung capacity (TLC) is the maximum volume of air the lungs can hold and is measured by lung plethysmography. | 3 months | |
Secondary | Change in ventilation/ perfusion abnormalities (VE/VCO2) | The ventilation/ perfusion abnormalities (VE/VCO2)is measured by graded exercise testing.
A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). |
3 months | |
Secondary | Change in left ventricular function: O2 pulse | O2 Pulse is simply oxygen consumption (in ml) divided by heart rate. It is used as an index of stroke volume. The O2 pulse is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). | 3 months | |
Secondary | Change in heart rate recovery | The heart rate recovery is measured by graded exercise testing, including 1 minute and 2 minute recovery.
A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). |
3 months | |
Secondary | Change in maximal heart rate (HRmax) | The maximal heart rate is measured by graded exercise testing, including 1 minute and 2 minute recovery. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). | 3 months | |
Secondary | Change in maximal blood pressure (BPmax) | The maximal heart rate is measured by graded exercise testing, including 1 minute and 2 minute recovery.
A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). |
3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|